Literature DB >> 1542924

A case of transfusion-associated graft-versus-host disease not prevented by white cell-reduction filters.

M Akahoshi1, M Takanashi, M Masuda, H Yamashita, A Hidano, K Hasegawa, T Kasajima, M Shimizu, T Motoji, K Oshimi.   

Abstract

A case of transfusion-associated graft-versus-host disease (TA-GVHD) in a patient with non-Hodgkin's lymphoma is reported. The patient, a 67-year-old woman, was diagnosed as having diffuse, mixed type non-Hodgkin's lymphoma, at clinical stage IIIA. She was treated with combination chemotherapy and received multiple blood transfusions for anemia and thrombocytopenia. Although white cells (WBCs) were reduced in the transfused components by WBC-reduction filters, the patient developed TA-GVHD that was confirmed by skin biopsy. It is suggested that the WBC reduction attained with these filters does not prevent TA-GVHD in immunocompromised patients. It is recommended that all blood components should be irradiated before transfusion to such patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1542924     DOI: 10.1046/j.1537-2995.1992.32292180149.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  10 in total

Review 1.  Leucoreduction of blood components: an effective way to increase blood safety?

Authors:  Maria Bianchi; Stefania Vaglio; Simonetta Pupella; Giuseppe Marano; Giuseppina Facco; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-12-16       Impact factor: 3.443

2.  Absence of transfusion-associated microchimerism in pediatric and adult recipients of leukoreduced and gamma-irradiated blood components.

Authors:  Rosa Sanchez; Tzong-Hae Lee; Li Wen; Leilani Montalvo; Cathy Schechterly; Camilla Colvin; Harvey J Alter; Naomi L C Luban; Michael P Busch
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

Review 3.  Irradiation in the prevention of transfusion associated graft-versus-host disease.

Authors:  D K Webb
Journal:  Arch Dis Child       Date:  1995-11       Impact factor: 3.791

Review 4.  Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.

Authors:  James Lm Ferrara; Christopher M Smith; Julia Sheets; Pavan Reddy; Jonathan S Serody
Journal:  J Clin Invest       Date:  2017-06-05       Impact factor: 14.808

Review 5.  Blood transfusion in newborn.

Authors:  M Mahapatra; V P Choudhry
Journal:  Indian J Pediatr       Date:  2003-11       Impact factor: 1.967

6.  Understanding loss of donor white blood cell immunogenicity after pathogen reduction: mechanisms of action in ultraviolet illumination and riboflavin treatment.

Authors:  Rachael P Jackman; John W Heitman; Susanne Marschner; Raymond P Goodrich; Philip J Norris
Journal:  Transfusion       Date:  2009-08-04       Impact factor: 3.157

7.  Red blood cell transfusions in newborn infants: Revised guidelines.

Authors: 
Journal:  Paediatr Child Health       Date:  2002-10       Impact factor: 2.253

8.  Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis.

Authors:  Sukjoo Cho; Jonghanne Park; Misuk Lee; Dongyup Lee; Horyun Choi; Gahyun Gim; Leeseul Kim; Cyra Y Kang; Youjin Oh; Pedro Viveiros; Elena Vagia; Michael S Oh; Geum Joon Cho; Ankit Bharat; Young Kwang Chae
Journal:  Transl Lung Cancer Res       Date:  2021-04

9.  Prevention of transfusion-associated graft-versus-host disease by irradiation: technical aspect of a new ferrous sulphate dosimetric system.

Authors:  Lucas Sacchini Del Lama; Evamberto Garcia de Góes; Paulo César Dias Petchevist; Edson Lara Moretto; José Carlos Borges; Dimas Tadeu Covas; Adelaide de Almeida
Journal:  PLoS One       Date:  2013-06-07       Impact factor: 3.240

10.  Double-filtered leukoreduction as a method for risk reduction of transfusion-associated graft-versus-host disease.

Authors:  Sejong Chun; Minh-Trang Thi Phan; Saetbyul Hong; Jehoon Yang; Yeup Yoon; Sangbin Han; Jungwon Kang; Mark H Yazer; Jaehyun Kim; Duck Cho
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.